Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 9/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 4/20 | 0.37 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.37 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.37 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | BACE1 | P56817 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL363065 | 1.00 | CA2 (0.42) | CA2MAPK1ALDH1A1TSHRCYP3A4 | |
| SCHEMBL8930168 | 0.84 | CA2 (0.39) | CA2MAPK1ALDH1A1TSHRCYP3A4 | |
| SCHEMBL973522 | 0.83 | CA2 (0.50) | CA2MAPK1TDP1CA1SLC1A3 | |
| SCHEMBL973520 | 0.83 | CA2 (0.50) | CA2MAPK1TDP1CA1SLC1A3 | |
| SCHEMBL3034500 | 0.78 | CA2 (0.50) | CA2MAPK1CA1SLC1A2SLC1A1 | |
| SCHEMBL3039825 | 0.78 | CA2 (0.50) | CA2MAPK1CA1SLC1A2SLC1A1 | |
| SCHEMBL3034502 | 0.78 | CA2 (0.50) | CA2MAPK1CA1SLC1A2SLC1A1 | |
| SCHEMBL1121833 | 0.77 | CA2 (0.63) | CA2MAPK1ALDH1A1TSHRCYP3A4 | |
| SCHEMBL6829829 | 0.76 | CA2 (0.47) | CA2MAPK1SLC1A2SLC1A1 | |
| SCHEMBL6829832 | 0.76 | CA2 (0.47) | CA2MAPK1SLC1A2SLC1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 337 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200231795-A1 | PROCESS FOR PRODUCING HETEROPHASIC COPOLYMERS OF PROPYLENE | BOREALIS AG (AT) | 2020-07-23 | — | — | US | claimed |
| US-20190315953-A9 | PROCESS FOR PRODUCING HETEROPHASIC COPOLYMERS OF PROPYLENE | BOREALIS AG (AT) | 2019-10-17 | — | — | US | claimed |
| US-20180244904-A1 | PROCESS FOR PRODUCING HETEROPHASIC COPOLYMERS OF PROPYLENE | BOREALIS AG (AT) | 2018-08-30 | — | — | US | claimed |
| EP-3259315-A1 | PROCESS FOR PRODUCING HETEROPHASIC COPOLYMERS OF PROPYLENE | Borealis AG (AT) | 2017-12-27 | — | — | EP | claimed |
| WO-2016131907-A1 | PROCESS FOR PRODUCING HETEROPHASIC COPOLYMERS OF PROPYLENE | BOREALIS AG (AT) | 2016-08-25 | — | — | WO | claimed |
| US-12565578-B2 | Polypropylene-polyethylene blends with improved properties | BOREALIS AG (AT) | 2026-03-03 | — | — | US | disclosed |
| US-12534553-B2 | Stiff blown film | BOREALIS AG (AT) | 2026-01-27 | — | — | US | disclosed |
| US-12509577-B2 | Heterophasic propylene polymer composition with improved property profile | BOREALIS AG (AT) | 2025-12-30 | — | — | US | disclosed |
| US-12497470-B2 | C2C3 random copolymer | BOREALIS AG (AT) | 2025-12-16 | — | — | US | disclosed |
| US-20250313687-A1 | GLASS FIBER COMPOSITE | BOREALIS AG (AT) | 2025-10-09 | — | — | US | disclosed |
| EP-3875503-B1 | CATALYST AND PREPARATION THEREOF | BOREALIS GMBH (AT) | 2025-10-08 | — | — | EP | disclosed |
| US-20250250400-A1 | A PROCESS FOR RECYCLING POLYPROPYLENE FILMS | BOREALIS AG (AT) | 2025-08-07 | — | — | US | disclosed |
| US-8901261-B2 | Catalyst component | BOREALIS AG (AT) | 2014-12-02 | — | — | US | disclosed |
| EP-2415790-B1 | Catalyst component | BOREALIS AG (AT) | 2014-09-24 | — | — | EP | disclosed |
| US-20130253156-A1 | CATALYST COMPONENT | BOREALIS AG (AT) | 2013-09-26 | — | — | US | disclosed |
| US-20130116393-A1 | CATALYST COMPONENT | BOREALIS AG (AT) | 2013-05-09 | — | — | US | disclosed |
| EP-2570438-A2 | Catalyst component | Borealis AG (AT) | 2013-03-20 | — | — | EP | disclosed |
| EP-2415790-A1 | Catalyst component | Borealis AG (AT) | 2012-02-08 | — | — | EP | disclosed |
| WO-2012007427-A1 | CATALYST COMPONENT | BOREALIS AG (AT) | 2012-01-19 | — | — | WO | disclosed |
| WO-2012007430-A1 | CATALYST COMPONENT | BOREALIS AG (AT) | 2012-01-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12565578-B2 | Polypropylene-polyethylene blends with improved properties | XPA, CRHR2, LBR | CA2 4531/4885MAPK1 3668/4885ALDH1A1 4417/4885 |
| US-12534553-B2 | Stiff blown film | FPR2, MYH2, XRN2 | CA2 3335/4885MAPK1 3473/4885ALDH1A1 4872/4885 |
| US-12509577-B2 | Heterophasic propylene polymer composition with improved property profile | CRHR2, HRH2, FPR2 | CA2 3949/4885MAPK1 4358/4885ALDH1A1 4551/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.